Oramed Pharmaceuticals
ORMP
#9145
Rank
ยฃ0.12 B
Marketcap
ยฃ2.96
Share price
5.12%
Change (1 day)
66.32%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): ยฃ46.64 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of ยฃ47.21 Million, an increase over its 2024 earnings that were of -ยฃ11.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ46.64 M-1.19%
2025 ยฃ47.21 M-513.21%
2024 -ยฃ11.43 Million-311.47%
2023 ยฃ5.4 M-119.45%
2022 -ยฃ27.78 Million39.17%
2021 -ยฃ19.96 Million73.93%
2020 -ยฃ11.48 Million18.53%
2019 -ยฃ9.69 Million-16.62%
2018 -ยฃ11.62 Million38.32%
2017 -ยฃ8.4 Million12.51%
2016 -ยฃ7.47 Million25.01%
2015 -ยฃ5.97 Million18.18%
2014 -ยฃ5.05 Million39.72%
2013 -ยฃ3.62 Million46.4%
2012 -ยฃ2.47 Million128.32%
2011 -ยฃ1.09 Million-51.47%
2010 -ยฃ2.23 Million35.21%
2009 -ยฃ1.65 Million
2007 -ยฃ2.6 Million607.04%
2006 -ยฃ0.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
ยฃ17.42 B 36,485.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ5.90 B 12,296.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.34 Billion-811.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ46.35 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ26.45 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel